Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
Abstract Objective Reports of tuberculosis (TB) during anticancer treatment with immune checkpoint inhibitors (ICIs) are increasing. However, it is not clear whether the use of ICIs is a significant risk factor for TB, including reactivation or latent TB infection (LTBI). Methods To determine the ri...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2024
|
| 在线阅读: | https://doi.org/10.1093/oncolo/oyad340 https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad340/56147999/oyad340.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|